Skip to search formSkip to main contentSkip to account menu

Polycythemia Vera

Known as: Erythremias, Polycythemia Ruba Veras, Ruba Veras, Polycythemia 
A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute… 
National Institutes of Health

Related topics

Related topics

48 relations
Anagrelide hydrochlorideBlood supply aspectsBone MarrowBone Marrow Neoplasms

Broader (2)

Myeloproliferative diseasePolycythemia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
BACKGROUND The V617F mutation, which causes the substitution of phenylalanine for valine at position 617 of the Janus kinase (JAK… 
Review
2007
Review
2007
Physiology and neurobiology of stress and adaptation: central role of the brain.
The brain is the key organ of the response to stress because it determines what is threatening and, therefore, potentially… 
Review
2007
Review
2007
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc…
The Janus kinase 2 mutation, JAK2617V>F, is myeloid neoplasm-specific; its presence excludes secondary polycythemia… 
Highly Cited
2005
Highly Cited
2005
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Highly Cited
2005
Highly Cited
2005
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
Myeloproliferative disorders are clonal haematopoietic stem cell malignancies characterized by independency or hypersensitivity… 
Highly Cited
2005
Highly Cited
2005
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
PURPOSE The clinical course of polycythemia vera is often complicated by thrombosis as well as by the possible transition to… 
Highly Cited
2004
Highly Cited
2004
Efficacy and safety of low-dose aspirin in polycythemia vera.
BACKGROUND The use of aspirin for the prevention of thrombotic complications in polycythemia vera is controversial. METHODS We… 
Review
2004
Review
2004
Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
The focus of this review is to provide an overview of the current state of knowledge of molecular mechanisms/processes that… 
Review
2002
Review
2002
Polycythemia vera: myths, mechanisms, and management.
Polycythemia vera is a clonal disorder arising in a multipotent hematopoietic progenitor cell that causes the accumulation of… 
Review
2001
Review
2001
Spinal and supraspinal factors in human muscle fatigue.
Muscle fatigue is an exercise-induced reduction in maximal voluntary muscle force. It may arise not only because of peripheral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)